The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia
暂无分享,去创建一个
J. Qiu | Ziying Yan | M. Salathe | W. Zou | Min Xiong | E. Y. Zhang | N. Baumlin | Michael D. Kim | Siyuan Hao | Nathalie Baumlin
[1] Evan T. Sholle,et al. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions , 2021, Nature Communications.
[2] D. Qu,et al. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry , 2021, Nature Communications.
[3] G. Benard,et al. COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients , 2021, Frontiers in Physiology.
[4] Vineet D. Menachery,et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.
[5] G. Whittaker,et al. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin , 2021, ACS infectious diseases.
[6] A. Krishnan,et al. COVID-19: An overview and a clinical update , 2021, World journal of clinical cases.
[7] Melissa N. Thone,et al. COVID-19 vaccines: The status and perspectives in delivery points of view , 2020, Advanced Drug Delivery Reviews.
[8] J. Qiu,et al. The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region , 2020, Viruses.
[9] J. Qiu,et al. Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium , 2020, mBio.
[10] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[11] A. Helenius,et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.
[12] Zhènglì Shí,et al. Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.
[13] Zhichao Miao,et al. Secondary structure of the SARS-CoV-2 5’-UTR , 2020, RNA biology.
[14] Yvette N. Lamb. Remdesivir: First Approval , 2020, Drugs.
[15] Y. Orba,et al. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells , 2020, bioRxiv.
[16] D. Qu,et al. The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission , 2020, bioRxiv.
[17] K. To,et al. Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein , 2020, bioRxiv.
[18] A. McElroy,et al. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients , 2020, The Journal of general virology.
[19] Wenling Wang,et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells , 2020, Nature Communications.
[20] D. Matthews,et al. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein , 2020, Genome Medicine.
[21] K. To,et al. Natural transmission of bat-like SARS-CoV-2ΔPRRA variants in COVID-19 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Zhang,et al. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Journal of Virology.
[23] A. Alsheikh-Ali,et al. SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission , 2020, bioRxiv.
[24] G. Whittaker,et al. Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site , 2020, iScience.
[25] Alice C Hughes,et al. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein , 2020, Current Biology.
[26] Fang Li,et al. Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.
[27] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[28] M. Hoffmann,et al. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.
[29] Fabian J Theis,et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues , 2020, Cell.
[30] Natacha S. Ogando,et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology , 2020, bioRxiv.
[31] Jiaofeng Huang,et al. The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis , 2020, Journal of medical virology.
[32] Susan Daniel,et al. Coronavirus membrane fusion mechanism offers a potential target for antiviral development , 2020, Antiviral Research.
[33] Hyeshik Chang,et al. The Architecture of SARS-CoV-2 Transcriptome , 2020, Cell.
[34] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[35] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[36] K. Yuen,et al. SARS-CoV-2 is an appropriate name for the new coronavirus , 2020, The Lancet.
[37] B. Canard,et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade , 2020, Antiviral Research.
[38] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[39] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[40] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[41] Z. Memish,et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.
[42] K. To,et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan , 2020, Emerging microbes & infections.
[43] K. To,et al. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction , 2020, Emerging microbes & infections.
[44] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report , 2017, Respirology.
[45] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.
[46] Fang Li,et al. Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.
[47] I. Brierley,et al. High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling , 2016, PLoS pathogens.
[48] I. Sola,et al. Continuous and Discontinuous RNA Synthesis in Coronaviruses. , 2015, Annual review of virology.
[49] S. Perlman,et al. Coronaviruses: An Overview of Their Replication and Pathogenesis , 2015, Methods in molecular biology.
[50] Stuart G. Siddell,et al. A Contemporary View of Coronavirus Transcription , 2006, Journal of Virology.
[51] C. Schwegmann-Wessels,et al. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. , 2006, The Journal of general virology.
[52] S. Alonso,et al. Sequence Motifs Involved in the Regulation of Discontinuous Coronavirus Subgenomic RNA Synthesis , 2004, Journal of Virology.
[53] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[54] Peter Cameron,et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.
[55] D. Brian,et al. Minus-strand copies of replicating coronavirus mRNAs contain antileaders , 1991, Journal of virology.